Jubilant Pharmova Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jubilant Pharmova Limited has informed the stock exchanges that its trading window will be closed starting Tuesday, July 01, 2025, and will reopen 48 hours after the announcement of its financial results for the quarter ending June 30, 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, meaning directors, employees, and other designated persons cannot buy or sell company shares during this period. The exact date of the board meeting to declare the Q1 FY26 results has not been announced yet and will be communicated later.
This is a standard regulatory disclosure with no direct impact on the stock price or business. Investors should watch for the upcoming Q1 FY26 results announcement, which is expected later in July 2025.